260 related articles for article (PubMed ID: 28119367)
1. HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer.
Dong J; Wang R; Ren G; Li X; Wang J; Sun Y; Liang J; Nie Y; Wu K; Feng B; Shang Y; Fan D
Clin Cancer Res; 2017 Jul; 23(13):3461-3473. PubMed ID: 28119367
[No Abstract] [Full Text] [Related]
2. HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
Li W; Wang Z; Zha L; Kong D; Liao G; Li H
Oncol Rep; 2017 Jan; 37(1):185-192. PubMed ID: 27878307
[TBL] [Abstract][Full Text] [Related]
3. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
4. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
5. HMGA2 regulates lung cancer proliferation and metastasis.
Gao X; Dai M; Li Q; Wang Z; Lu Y; Song Z
Thorac Cancer; 2017 Sep; 8(5):501-510. PubMed ID: 28752530
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
Zha L; Zhang J; Tang W; Zhang N; He M; Guo Y; Wang Z
Dig Dis Sci; 2013 Mar; 58(3):724-33. PubMed ID: 23135750
[TBL] [Abstract][Full Text] [Related]
8. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells.
Zha L; Wang Z; Tang W; Zhang N; Liao G; Huang Z
Mol Cell Biochem; 2012 May; 364(1-2):243-51. PubMed ID: 22246783
[TBL] [Abstract][Full Text] [Related]
10. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.
Kong F; Sun T; Kong X; Xie D; Li Z; Xie K
Clin Cancer Res; 2018 May; 24(10):2440-2451. PubMed ID: 29367428
[No Abstract] [Full Text] [Related]
13. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
14. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
15. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
17. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin α2.
Liu X; Liang Z; Gao K; Li H; Zhao G; Wang S; Fang J
Tumour Biol; 2016 Jun; 37(6):7951-7. PubMed ID: 26700675
[TBL] [Abstract][Full Text] [Related]
19. miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1.
Hu J; Shan Z; Hu K; Ren F; Zhang W; Han M; Li Y; Feng K; Lei L; Feng Y
Int J Oncol; 2016 Jul; 49(1):325-35. PubMed ID: 27212195
[TBL] [Abstract][Full Text] [Related]
20. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer.
Li X; Wang S; Li Z; Long X; Guo Z; Zhang G; Zu J; Chen Y; Wen L
Int J Biol Macromol; 2017 Dec; 105(Pt 1):346-353. PubMed ID: 28720546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
